IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue , 2016, Pages 16-24

  Bus, S A ^a   van Netten, J J ^b   Lavery, L A ^c   Monteiro Soares, M ^d   Rasmussen, A ^e   Jubiz, Y ^f   Price, P E ^g  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b TWENTEBORG HOSPITAL   (Netherlands)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d University of Porto   (Portugal)

^e STENO DIABETES CENTER   (Denmark)

^f Future Surgeons Chapter   (Colombia)

^g CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CHEMICAL AGENT; EMOLLIENT AGENT;

ACHILLES TENDON; ANTIMICROBIAL THERAPY; ARTHROPLASTY; ARTICLE; BLEEDING; BLISTER; CALLOSITY; CALLUS; CLINICAL EXAMINATION; CONSERVATIVE TREATMENT; DIABETIC FOOT; DIABETIC PATIENT; DRY SKIN; FOOT CARE; FOOT MALFORMATION; HIGH RISK PATIENT; HUMAN; INGROWN NAIL; KNOWLEDGE; LEG AMPUTATION; LUBRICATION; MEDICAL HISTORY; MYCOSIS; NERVE DECOMPRESSION; OSTEOTOMY; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERSONAL HYGIENE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; SELF CARE; SELF EVALUATION; SHOE; SKIN TEMPERATURE; TENOTOMY; WALKING; ADVERSE EFFECTS; COMPLICATION; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DISEASE COURSE; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HEALTH; INTERNATIONAL COOPERATION; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; PRIMARY HEALTH CARE; RISK FACTOR; TRENDS;

COMBINED MODALITY THERAPY; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; INTERNATIONAL AGENCIES; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PRECISION MEDICINE; PRIMARY HEALTH CARE; RECURRENCE; RISK FACTORS; SELF CARE; SHOES;

EID: 84956824332     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2696     Document Type: Article

References (68)

1. International Working Group on the Diabetic foot. International consensus on the diabetic foot and practical guidelines on the management and the prevention of the diabetic foot, 2011.
2. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabet Med 2014; 31(12): 1498-1504.
3. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50(1): 18-25.
4. Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med 2005; 22(10): 1306-1309.
5. Bus SA, Waaijman R, Arts M, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care 2013; 36: 4109-4116.
6. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158(2): 157-162.
7. Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 2011; 54(5): 1190-1199.
8. Van Netten JJ, Price PE, Lavery LA, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes Metab Res Rev 2015. DOI:10.1002/dmrr.2701
9. Hinchliffe RJ, Brownrigg JR, Apelqvist J, et al. IWGDF Guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes Metab Res Rev 2015. DOI:10.1002/dmrr.2698.
10. Waaijman R, de Haart M, Arts ML, et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care 2014; 37: 1697-1705.
11. Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complications 1990; 4(1): 21-25.
12. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999; 22(1): 157-162.
13. Young MJ, Cavanagh PR, Thomas G, Johnson MM, Murray H, Boulton AJ. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet Med 1992; 9(1): 55-57.
14. Pitei DL, Foster A, Edmonds M. The effect of regular callus removal on foot pressures. J Foot Ankle Surg 1999; 38: 251-255; discussion 306.
15. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000; 23(5): 606-611.
16. Rizzo L, Tedeschi A, Fallani E, et al. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Low Extrem Wounds 2012; 11: 59-64.
17. Lavery LA, LaFontaine J, Higgins KR, Lanctot DR, Constantinides G. Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients. Adv Skin Wound Care 2012; 25: 519-524; quiz 525-6.
18. Scire V, Leporati E, Teobaldi I, Nobili LA, Rizzo L, Piaggesi A. Effectiveness and safety of using Podikon digital silicone padding in the primary prevention of neuropathic lesions in the forefoot of diabetic patients. J Am Podiatr Med Assoc 2009; 99: 28-34.
19. Ulbrecht JS, Hurley T, Mauger DT, Cavanagh PR. Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care 2014; 37: 1982-1989.
20. Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002; 287: 2552-2558.
21. Viswanathan V, Madhavan S, Rajasekar S, Chamukuttan S, Ambady R. Amputation prevention initiative in South India: positive impact of foot care education. Diabetes Care 2005; 28: 1019-1021.
22. Calle-Pascual A, Duran A, Benedi A, et al. Reduction in foot ulcer incidence: relation to compliance with a prophylactic foot care program. Diabetes Care 2001; 24: 405-407.
23. Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ. Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 1999; 22: 1428-1431.
24. Plank J, Haas W, Rakovac I, et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects. Diabetes Care 2003; 26: 1691-1695.
25. Hamonet J, Verdie-Kessler C, Daviet JC, et al. Evaluation of a multidisciplinary consultation of diabetic foot. [French]. Ann Phys Rehabil Med 2010; 53: 306-318.
26. Armstrong DG, Harkless LB. Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg 1998; 37: 460-466.
27. Marcinia M, Chantelau E. Qualified podiatry for rehabilitation of patients with diabetic foot syndrome. A cohort study. Diabetes und Stoffwechsel 1998; 7: 81-85.
28. Lincoln NB, Radford KA, Game FL, Jeffcoate WJ. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008; 51: 1954-1961.
29. Gershater MA, Pilhammar E, Apelqvist J, Alm-Roijer C. Patient education for the prevention of diabetic foot ulcers. Interim analysis of a randomised controlled trial due to morbidity and mortality of participants. Eur Diabetes Nurs 2011; 8: 102-107b.
30. Skrepnek GH, Mills JL, Armstrong DG. Foot-in-wallet disease: tripped up by "cost-saving" reductions? Diabetes Care 2014; 37(9): e196-e197.
31. Lavery LA, Higgins KR, Lanctot DR, et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004; 27(11): 2642-2647.
32. Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients. Am J Med 2007; 120: 1042-1046.
33. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care 2007; 30(1): 14-20.
34. Van Netten JJ, Prijs M, van Baal JG, Liu C, van der Heijden F, Bus SA. Diagnostic values for skin temperature assessment to detect diabetes-related foot complications. Diabetes Technol Ther 2014; 16(11): 714-721.
35. Kearney TP, Hunt NA, Lavery LA. Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes. Diabetes Res Clin Pract 2010 Sep; 89(3): 224-226.
36. Laborde JM. Neuropathic toe ulcers treated with toe flexor tenotomies. Foot Ankle Int 2007; 28(11): 1160-1164.
37. Rasmussen A, Bjerre-Christensen U, Almdal TP, Holstein P. Percutaneous flexor tenotomy for preventing and treating toe ulcers in people with diabetes mellitus. J Tissue Viability 2013; 22: 68-73.
38. Schepers T, Berendsen HA, Oei IH, Koning J. Functional outcome and patient satisfaction after flexor tenotomy for plantar ulcers of the toes. J Foot Ankle Surg 2010; 49(2): 119-122.
39. Tamir E, Vigler M, Avisar E, Finestone AS. Percutaneous tenotomy for the treatment of diabetic toe ulcers. Foot Ankle Int 2014; 35(1): 38-43.
40. Tamir E, McLaren AM, Gadgil A, Daniels TR. Outpatient percutaneous flexor tenotomies for management of diabetic claw toe deformities with ulcers: a preliminary report. Can J Surg 2008; 51(1): 41-44.
41. Van Netten JJ, Bril A, van Baal JG. The effect of flexor tenotomy on healing and prevention of neuropathic diabetic foot ulcers on the distal end of the toe. J Foot Ankle Res 2013; 6: 3.
42. Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003; 85-a: 1436-1445.
43. Colen LB, Kim CJ, Grant WP, Yeh JT, Hind B. Achilles tendon lengthening: friend or foe in the diabetic foot? Plast Reconstr Surg 2012; 131: 37e-43e.
44. Cunha M, Faul J, Steinberg J, Attinger C. Forefoot ulcer recurrence following partial first ray amputation: the role of tendo-Achilles lengthening. J Am Podiatr Med Assoc 2010; 100: 80-82.
45. Holstein P, Lohmann M, Bitsch M, Jorgensen B. Achilles tendon lengthening, the panacea for plantar forefoot ulceration? Diabetes Metab Res 2004; 20(Suppl 1): S37-S40.
46. Lee TH, Lin SS, Wapner KL. Tendo-Achilles lengthening and total contact casting for plantar forefoot ulceration in diabetic patients with equinus deformity of the ankle. Operat Tech Orthop 1996; 6: 222-225.
47. Laborde JM. Neuropathic plantar forefoot ulcers treated with tendon lengthenings. Foot Ankle Int 2008; 29: 378-384.
48. Laborde JM. Midfoot ulcers treated with gastrocnemius-soleus recession. Foot Ankle Int 2009; 30: 842-846.
49. Piaggesi A, Schipani E, Campi F, et al. Conservative surgical approach versus non-surgical management for diabetic neuropathic foot ulcers: a randomized trial. Diabet Med 1998; 15(5): 412-417.
50. Armstrong DG, Rosales MA, Gashi A. Efficacy of fifth metatarsal head resection for treatment of chronic diabetic foot ulceration. J Am Podiatr Med Assoc 2005; 95: 353-356.
51. Faglia E, Clerici G, Caminiti M, Curci V, Somalvico F. Feasibility and effectiveness of internal pedal amputation of phalanx or metatarsal head in diabetic patients with forefoot osteomyelitis. J Foot Ankle Surg 2012; 51: 593-598.
52. Giurini JM, Basile P, Chrzan JS, Habershaw GM, Rosenblum BI. Panmetatarsal head resection. A viable alternative to the transmetatarsal amputation. J Am Podiatr Med Assoc 1993; 83: 101-107.
53. Hamilton GA, Ford LA, Perez H, Rush SM. Salvage of the neuropathic foot by using bone resection and tendon balancing: a retrospective review of 10 patients. J Foot Ankle Surg 2005; 44: 37-43.
54. Petrov O, Pfeifer M, Flood M, Chagares W, Daniele C. Recurrent plantar ulceration following pan metatarsal head resection. J Foot Ankle Surg 1996; 35: 573-577; discussion 602.
55. Molines-Barroso R, Lazaro-Martinez J, Aragon-Sanchez J, Garcia-Morales E, Beneit-Montesinos J, Alvaro-Afonso F. Analysis of transfer lesions in patients who underwent surgery for diabetic foot ulcers located on the plantar aspect of the metatarsal heads. Diabet Med 2013; 30: 973-976.
56. Griffiths GD, Wieman TJ. Metatarsal head resection for diabetic foot ulcers. Arch Surg 1990; 125: 832-835.
57. Armstrong DG, Lavery LA, Vazquez JR, et al. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes. Diabetes Care 2003; 26: 3284-3287.
58. Lin SS, Bono CM, Lee TH. Total contact casting and Keller arthoplasty for diabetic great toe ulceration under the interphalangeal joint. Foot Ankle Int 2000; 21: 588-593.
59. Downs DM, Jacobs RL. Treatment of resistant ulcers on the plantar surface of the great toe in diabetics. J Bone Joint Surg Am 1982; 64: 930-933.
60. Vanlerberghe B, Devemy F, Duhamel A, Guerreschi P, Torabi D. Conservative surgical treatment for diabetic foot ulcers under the metatarsal heads. A retrospective case-control study. Ann Chir Plast Esthet 2014; 59(3): 161-169.
61. Fleischli JE, Anderson RB, Davis WH. Dorsiflexion metatarsal osteotomy for treatment of recalcitrant diabetic neuropathic ulcers. Foot Ankle Int 1999; 20: 80-85.
62. Salsich GB, Mueller MJ, Hastings MK, Sinacore DR, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on ankle muscle performance in people with diabetes mellitus and a neuropathic plantar ulcer. Phys Ther 2005; 85(1): 34-43.
63. Nickerson DS, Rader AJ. Nerve decompression after diabetic foot ulceration may protect against recurrence: a 3-year controlled, prospective analysis. J Am Podiatr Med Assoc 2014; 104: 66-70.
64. Nickerson DS. Low recurrence rate of diabetic foot ulcer after nerve decompression. J Am Podiatr Med Assoc 2010; 100: 111-115.
65. Dellon AL, Muse VL, Nickerson DS, et al. Prevention of ulceration, amputation, and reduction of hospitalization: outcomes of a prospective multicenter trial of tibial neurolysis in patients with diabetic neuropathy. J Reconstr Microsurg 2012; 28: 241-246.
66. Nickerson DS, Rader AJ. Low long-term risk of foot ulcer recurrence after nerve decompression in a diabetes neuropathy cohort. J Am Podiatr Med Assoc 2013; 103: 380-386.
67. Aszmann O, Tassler PL, Dellon AL. Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure. Ann Plast Surg 2004; 53: 517-522.
68. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924-926.